Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$122 Billion
Q2 2025

A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 14,702 shares of ARWR stock, worth $565,585. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,702

Previous 14,476 1.56%

Holding current value

$565,585

Previous $184,000 26.09%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	BUY	$9.99 - $16.97 $2,257 - $3,835	226 Added 1.56%	14,702 $232,000
Q1 2025 May 12, 2025	BUY	$12.74 - $21.53 $15,224 - $25,728	1,195 Added 9.0%	14,476 $184,000
Q4 2024 Feb 12, 2025	BUY	$17.7 - $26.34 $45,241 - $67,325	2,556 Added 23.83%	13,281 $249,000
Q3 2024 Nov 07, 2024	SELL	$19.36 - $29.54 $19,224 - $29,333	-993 Reduced 8.47%	10,725 $207,000
Q2 2024 Aug 12, 2024	BUY	$21.87 - $28.24 $73,854 - $95,366	3,377 Added 40.49%	11,718 $304,000
Q1 2024 May 09, 2024	SELL	$27.21 - $39.48 $10,149 - $14,726	-373 Reduced 4.28%	8,341 $238,000
Q4 2023 Feb 08, 2024	BUY	$21.2 - $31.03 $20,182 - $29,540	952 Added 12.26%	8,714 $266,000
Q3 2023 Nov 07, 2023	BUY	$26.2 - $36.08 $5,502 - $7,576	210 Added 2.78%	7,762 $208,000
Q2 2023 Aug 09, 2023	SELL	$25.16 - $41.38 $27,298 - $44,897	-1,085 Reduced 12.56%	7,552 $269,000
Q4 2022 Feb 07, 2023	BUY	$28.0 - $40.56 $44,352 - $64,247	1,584 Added 22.46%	8,637 $350,000
Q3 2022 Nov 01, 2022	SELL	$29.63 - $48.31 $1,037 - $1,690	-35 Reduced 0.49%	7,053 $233,000
Q2 2022 Aug 04, 2022	BUY	$27.79 - $50.61 $76,950 - $140,139	2,769 Added 64.11%	7,088 $250,000
Q1 2022 May 09, 2022	BUY	$39.62 - $69.97 $10,063 - $17,772	254 Added 6.25%	4,319 $199,000
Q4 2021 Feb 07, 2022	SELL	$58.09 - $82.51 $15,277 - $21,700	-263 Reduced 6.08%	4,065 $284,000
Q2 2021 Aug 06, 2021	SELL	$62.15 - $90.32 $65,879 - $95,739	-1,060 Reduced 19.67%	4,328 $358,000
Q1 2021 May 06, 2021	BUY	$61.35 - $90.47 $113,865 - $167,912	1,856 Added 52.55%	5,388 $357,000
Q4 2020 Feb 09, 2021	SELL	$43.82 - $85.37 $76,728 - $149,482	-1,751 Reduced 33.14%	3,532 $271,000
Q3 2020 Nov 10, 2020	BUY	$33.21 - $51.27 $2,523 - $3,896	76 Added 1.46%	5,283 $227,000
Q2 2020 Aug 06, 2020	BUY	$26.12 - $43.27 $136,006 - $225,306	5,207 New	5,207 $225,000

Others Institutions Holding ARWR

# of Institutions

323

Shares Held

99.5M

Call Options Held

444K

Put Options Held

568K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $4.07B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account

Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Arrowhead Pharmaceuticals, Inc. Transaction History